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Abstract We report here that the checkpoint kinase Chk1 and
the inhibitor of apoptosis protein (IAP) family member XIAP
can be found in a complex in association with condensed chro-
mosomes aligned at the metaphase plate during mitosis. The
interaction between Chk1 and XIAP was transient and followed
the breakdown of the nuclear envelope. Chk1 and XIAP also
formed a complex in vitro and in coimmunoprecipitation experi-
ments. The interaction between Chk1 and the BIR3 domain of
XIAP in vitro required an N-terminal sequence in Chk1 that is
identical to the BIR-binding motif at the N-terminus of HID.
An interaction of Chk1 and XIAP may imply a mechanism of
coupling between the regulatory networks that control cell cycle
progression and apoptosis during mitosis.
+ 2004 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
The existence of an interdependence between cell cycle con-
trol and the regulation of apoptotic cell death has been sug-
gested. However, the way in which cell cycle regulation and
apoptosis intersect is still for the most part unknown.
Chk1, an evolutionarily conserved dual-speci¢city protein
kinase, has a role in preventing progression into mitosis in
the presence of DNA damage [1,2]. In mammalian cells, how-
ever, Chk1 is expressed and active as a kinase during the
transition from S phase to M phase [3] and regulates
Cdc25A function [4] in the absence of DNA damage. Disrup-
tion of both alleles of Chk1 in mice results in embryonic
lethality associated with massive, p53-independent apoptosis
at the blastocyst stage [5,6].
The role of the inhibitor of apoptosis [7] family of proteins
(IAP), which contain one or more zinc-binding motifs named
baculoviral IAP repeat (BIR) [8] domains, has long been es-
tablished in the control of apoptosis through direct inhibition
of caspases [9,7]. Recently, a member of the IAP family,
named survivin/Tiap in mammals, was also implicated in the
control of chromosome segregation and cytokinesis, hinting at
the possibility that members of the IAP family may have a
role both in the regulation of apoptosis and in the control of
cell division [10^12]. The three best characterized IAP family
members, XIAP, cIAP1 and cIAP2, interact with and inhibit
caspase-3 and caspase-7, while XIAP binds and inhibits cas-
pase-9, as well. The BIR3 domain of XIAP interacts with
processed caspase-9 while caspase-3 and -7 contact XIAP
through the linker region upstream of its BIR2 domain [13].
The N-terminal four residues of the mammalian pro-apoptotic
molecule Smac/DIABLO and those of processed caspase-9
compete for the same binding groove on the BIR3 domain
of XIAP. Thus, Smac/DIABLO is thought to function by
relieving XIAP inhibition of caspase-9 activity [14]. The N-ter-
minal motif of Smac/DIABLO is present in the pro-apoptotic
Drosophila proteins Grim, Reaper and Hid as well, suggesting
that this mode of activation of apoptosis is evolutionarily
conserved.
We report in the present study that a motif homologous to
the sequences that target processed caspase-9 and Smac/DIA-
BLO to the BIR3 domain of XIAP is present at the N-termi-
nus of Chk1. Chk1 bound the BIR3 domain of XIAP and
cIAP1 in vitro, and XIAP was present in complexes immuno-
precipitated with Chk1 from cultured cells. Mutation of the
Chk1 N-terminal AVP motif was su⁄cient to disrupt its in-
teraction with the BIR3 domain of XIAP but did not a¡ect
Chk1 binding to the BIR3 domain of cIAP1 in vitro. The
interaction of Chk1 and XIAP appeared to be restricted to
mitosis and occurred after the disruption of the nuclear enve-
lope at prometaphase. During mitosis, Chk1 associated with
XIAP in juxtaposition with condensed chromosomes aligned
at the metaphase plate.
Chk1 may be the ¢rst BIR-interacting protein for which a
function in the regulation of apoptosis has not been described.
An interaction between Chk1 and IAPs may have a role in the
cross-talk between the mechanisms that drive apoptosis and
those that control the cell cycle.
2. Materials and methods
2.1. Cell culture and transient transfections
L929, HeLa and HEK293 cells were grown in Dulbecco’s modi¢ed
Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum
(FBS). Wild-type and catalytically inactive (D130A) human Chk1
(hChk1) expression vectors were described previously [1] and were
kindly provided by S. Elledge. HEK293 cells were transfected with
3^5 or 6^8 Wg of control (pcDNA3.1) or hChk1 plasmid constructs
respectively using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions. The amount of plasmid DNA transfected
was equalized by the addition of pcDNA3.1 vector DNA. Thirteen to
15 h after transfection, cells were lysed in 1 mM EDTA, 20 mM Tris^
HCl pH 7.5, 150 mM NaCl, 5 mM EGTA, 1% Triton X-100, 0.1%
NP-40, 0.5% sodium deoxycholate and Mini protease inhibitors
(Roche) (lysis bu¡er).
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2.2. Western blotting
Synchronized-released HeLa cells were collected at the times indi-
cated in the ¢gures and resuspended in lysis bu¡er. Lysates were spun
at 16 000Ug. Equivalent amounts of protein from supernatants were
resolved in denaturing gels (Invitrogen) and immunoblotted with the
antibodies indicated, or used in immunoprecipitation assays.
2.3. Immuno£uorescence assays
L929 cells were grown on 8-well slides and either left untreated or
incubated in 0.2 Wg/ml nocodazole for 16 h in the absence of serum,
¢xed by immersion in 320‡C methanol and blocked in 10% normal
donkey serum (Jackson ImmunoResearch Laboratories) and 1% bo-
vine serum albumin (BSA) in 1Uphosphate-bu¡ered saline (PBS) for
1 h at room temperature (RT). L929 cells were incubated with poly-
clonal anti-Chk1(FL-476) (Santa Cruz Biotechnology) and mouse
anti-XIAP (StressGen). Synchronized HeLa cells were incubated in
a mixture of rabbit anti-Chk1 (PEP, kindly provided by S. Elledge)
and rabbit anti-Chk1(FL-476) and mouse anti-XIAP. In all cases,
incubation was done in 1% BSA for 1 h at RT, followed by three
PBS washes and incubation with £uorescein isothiocyanate (FITC)-
conjugated, donkey anti-mouse and Texas Red-conjugated, donkey
anti-rabbit antibodies (Jackson Laboratories) for 1 h at RT. Cells
were then washed extensively (8^10 times, 15 min) with PBS at
room temperature, mounted in DAPI-Vectashield (Vector Laborato-
ries) and visualized by confocal microscopy using a Nikon PCM-2000
Laser Confocal Scanning Microscope. Alternatively, asynchronous
HEK293 cells were ¢xed in 4% paraformaldehyde in PBS for 40
min at RT and processed for immuno£uorescence as described above.
Wide-¢eld images were acquired for unsynchronized HeLa cell cul-
tures using a Nikon Eclipse-800 microscope and appropriate ¢lters
and collected using Compix Simple PCI software.
2.4. Cell synchronization
HeLa cells were synchronized by a double-thymidine block. Brie£y,
cells were incubated in 2 mM thymidine for 19 h, washed twice with
pre-warmed PBS and released in 5% FBS DMEM for 10 h. Thymi-
dine was re-added to the cultures to a ¢nal concentration of 2 mM
and incubated for an additional 17 h. Cells were then washed twice
with pre-warmed PBS and placed into normal medium. This point, at
which 85% of cells are at the G1/S boundary (not shown), was des-
ignated t0. Cultures were either collected and subjected to lysis or
¢xed at the times indicated, processed for immunolocalization of
Chk1 and XIAP as described and visualized by confocal microscopy.
2.5. Glutathione S-transferase (GST) pulldown assays
GST fusion proteins of the BIR3 domains of XIAP and cIAP1 were
expressed and puri¢ed from bacteria as described [15]. The GST-
cIAP1(BIR3) expression construct was kindly provided by Dr. Cath-
erine L. Day [16]. The GST-XIAP(BIR3) expression construct was
generated as described [15]. Lysates from untreated or transiently
transfected HEK293 cells were spun at 16 000Ug for 5 min at 4‡C.
Supernatants were precleared with GST and then incubated with 20
Wg of the indicated GST fusion proteins or GST alone bound to
Sepharose 4B beads. Complexes were washed, resolved in gels and
probed with antibodies as described in the ¢gure legends. Ten-well,
4 mm wide-well polyacrylamide gels were used in all experiments to
maximize the sharpness and resolution of closely migrating bands. In
cases in which single experiment sample number exceeded what could
be run on a single gel, all procedures (sample handling, electropho-
retic runs and transfers, antibody incubations, membrane washes and
development) were done simultaneously to avoid variability due to
di¡erences in processing.
2.6. Immunoprecipitation
An agarose-conjugated anti-Chk1(FL-476) antibody was purchased
from Santa Cruz Biotechnology. To remove unbound IgGs, 500 Wg of
antibody was washed twice in 15 ml of bu¡ered 0.1% Triton X-100,
0.5% Na deoxycholate, 0.1% NP-40 and 3 mM dithiothreitol (DTT)
followed by ¢ve washes in 15 ml of PBS. The concentration of the
washed agarose-conjugated antibody was estimated by Coomassie
blue staining of the starting material and the agarose pellet after the
¢nal wash. 650 Wg of total protein from supernatants of synchronized
HeLa cells was precleared by incubation with Protein A/G-PLUS
agarose (Santa Cruz Biotechnology) for 30 min at 4‡C followed by
incubation with 3 Wg of washed, agarose-conjugated anti-Chk1 anti-
body overnight at 4‡C. Agarose pellets were washed twice with lysis
bu¡er, followed by three additional washes with 25 mM HEPES pH
7.6, 20 mM MgCl, 2 mM DTT, 1 mM sodium orthovanadate and 20
mM L-glycerophosphate. Disruption of the immunoprecipitated com-
plexes was done in Laemmli bu¡er (Invitrogen) at 55‡C to minimize
dissociation of the IgGs from the agarose matrix, and resolved in 7%
or 3^8% Tris-acetate gels (Invitrogen). The separated polypeptides
were immunoblotted with anti-XIAP monoclonal antibody and de-
tected with horseradish peroxidase-conjugated goat anti-mouse sec-
ondary antibodies (Vector Laboratories).
3. Results
3.1. Chk1 contains a BIR3-targeting motif at its N-terminus
A domain-based search for proteins that contain an N-ter-
minal motif homologous to the sequences that target pro-
cessed caspase-9 and Smac/DIABLO to the BIR3 domain of
XIAP revealed a motif in Chk1 (Fig. 1). The Chk1 N-terminal
motif is identical to the one present in Hid and homologous to
the N-terminus of processed caspase-9, Smac/DIABLO, Grim
and Reaper. The N-terminal motif present in Chk1 is con-
served in the human, mouse and Xenopus laevis homologs.
3.2. Chk1 and XIAP are found in perinuclear structures in
nocodazole-treated L929 cells
Chk1 has been localized to the nucleus [1,3], while XIAP is
thought to be strictly cytoplasmic [7]. Thinking that an inter-
action between Chk1 and XIAP would possibly require the
disruption of the nuclear envelope, we performed coimmuno-
localization studies in untreated and nocodazole-treated L929
cell cultures. Nocodazole is an inhibitor of microtubule poly-
merization/depolymerization that disrupts mitotic spindle
function. In the presence of nocodazole, dividing cells arrest
as they attempt to enter mitosis. In agreement with previous
reports, we found that Chk1 immunoreactivity was predom-
inantly nuclear and XIAP immunoreactivity was restricted to
the cytoplasm of untreated L929 cells. In contrast, Chk1 and
XIAP immunoreactivity colocalized in structures juxtaposed
to a DNA-containing compartment in 46% of L929 cells after
24 h of exposure to nocodazole (Fig. 2A). These results sug-
gested that an interaction between Chk1 and XIAP could
occur in intact cells and that this interaction might be depen-
dent on the breakdown of the nuclear envelope and be re-
stricted to mitosis.
3.3. Chk1 and XIAP are present in complexes associated with
condensed chromosomes aligned at the metaphase plate
To determine whether an interaction between Chk1 and
XIAP may be regulated by the cell cycle, we assayed HeLa
cells in double-thymidine block and release experiments fol-
lowed by coimmunolocalization (Fig. 2B). Synchronization
Fig. 1. Alignment of the N-terminal sequences of the indicated pro-
teins. The BIR3 domain-binding motif is highlighted.
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experiments were monitored by immunoblotting lysates with
phospho-CDC25C(Ser216)-speci¢c antibodies and anti-cas-
pase-3 antibodies as a loading control (Fig. 2C). To increase
the sensitivity of the Chk1 immunostain in synchronized
HeLa cells, we used a mixture of rabbit anti-Chk1(FL-476)
and rabbit anti-Chk1(PEP) in immunohistochemistry assays.
The use of two antibodies directed to di¡erent epitopes of the
same protein in a single immunoassay to extend the dynamic
range of staining has been described previously [17]. A com-
parison of the staining pattern of the mixture of anti-
Chk1(FL-476) and anti-Chk1(PEP) vs. anti-Chk1(FL-476)
alone in immunohistochemistry assays was determined in pre-
liminary experiments using HEK293 cells transiently trans-
fected with constructs encoding hChk1 and XIAP. Non-spe-
ci¢c binding was negligible, and not signi¢cantly di¡erent for
the mixture of anti-Chk1(FL-476) and anti-Chk1(PEP) vs.
anti-Chk1(FL-476) alone (not shown).
In agreement with our observations in unsynchronized
L929 cells and previous reports, Chk1 immunoreactivity was
found predominantly in punctate structures in the nuclear
compartment in HeLa cells during S phase (0^4 h after re-
lease). As released cells progressed through G2 (5^7.5 h),
Chk1 immunoreactivity was found also in the cytoplasm of
cells approaching mitosis (7.25^9 h) that had not yet under-
gone nuclear envelope breakdown. In these rounded cells,
Chk1 immunoreactivity in the cytoplasm appeared to be in-
creased (Fig. 2B, 7.25 h), while nuclear punctate staining de-
creased in some cells. The apparent increase in staining inten-
sity may be a consequence of rounded morphology of the cells
approaching mitosis. As cells progressed through G2 and en-
tered mitosis, XIAP immunoreactivity was redistributed to
discrete cytoplasmic structures juxtaposed to the nuclear com-
partment. In some cells, XIAP immunoreactivity formed ring-
like structures that were stable as long as the nucleus re-
mained intact, disappeared during mitosis, and seemed to
re-form in daughter cells immediately after cytokinesis (Fig.
2B, 6.5, 7.25 and 9.5 h). No association between Chk1- and
XIAP-immunoreactive signals could be detected through early
and late anaphase in synchronized-released HeLa cells (Fig.
2B, 3, 6.5 and 7.5 h). In cells undergoing mitosis (8^10 h after
release), however, Chk1 and XIAP were detected as com-
plexes associated with condensed chromosomes aligned at
the metaphase plate (Fig. 2B, 9.5 h). We found no evidence
of interaction between Chk1 and XIAP at other points in the
cell cycle in synchronization-release experiments performed in
HeLa cells (data not shown). To determine whether the ap-
parent increase in Chk1 immunoreactivity in cells entering
mitosis was due to an increase in total Chk1 protein, we
performed immunoblotting on synchronized-released HeLa
cell lysates. No signi¢cant di¡erences in the levels of Chk1
protein were found between lysates of HeLa cells at 6.5^7 h
and 7^7.5 h after release, although a small decrease in Chk1
levels was observed at 7.75^8 h. Total XIAP expression levels
were unchanged during S to M progression in HeLa cells (Fig.
2D). We concluded from these experiments that an interaction
between Chk1 and XIAP may be restricted to mitosis, and
may occur in association with condensed chromosomes
aligned at the metaphase plate. Cytoplasmic Chk1 localization
and function in phosphorylation of Cdc25 has been docu-
mented in Xenopus oocytes during normal cell cycle progres-
sion [18]. Di¡use cytoplasmic staining, accompanied by punc-
tate nuclear staining, was observed in human ¢broblasts
stained with anti-Chk1(PEP) antibody when imaged at low
magni¢cations [1]. Also, Kaneko and collaborators reported
the cell cycle-dependent regulation of Chk1 subcellular local-
ization and protein levels in HeLa cells [3].
To exclude the possibility that the XIAP-immunoreactive
ring-like structures detected in HeLa cells traversing the G2^
M boundary represented artifacts of methanol ¢xation, and to
determine whether these structures would be present in asyn-
chronous cultures, we ¢xed HeLa cell cultures with 4% para-
formaldehyde, then performed immunostaining with anti-
XIAP antibodies and counterstained with DAPI as in the
previous experiments. XIAP immunoreactivity formed ring-
Fig. 2. A: L929 cells were left untreated or treated with nocodazole
for 16 h, ¢xed and incubated with rabbit anti-Chk1(FL-476) and
mouse anti-XIAP antibodies followed by Texas Red-conjugated
anti-rabbit and FITC-conjugated anti-mouse antibodies. B: HeLa
cells were synchronized by a double-thymidine block, ¢xed at the
times indicated and incubated with rabbit anti-Chk1(FL-476) and
mouse anti-XIAP antibodies followed by Texas Red-conjugated
anti-rabbit and FITC-conjugated anti-mouse antibodies. C: Lysates
from synchronized-released HeLa cells were collected at the times
indicated, resolved in denaturing gels (Invitrogen) and immunoblot-
ted with the indicated antibodies. D: Synchronized-released HeLa
cell lysates were processed as in C. E: Asynchronous HEK293 cells
¢xed in 4% paraformaldehyde were processed as described in B.
Wide-¢eld images were acquired using Compix Simple PCI soft-
ware.
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like structures closely juxtaposed to the nucleus in cells ¢xed
with paraformaldehyde, ruling out the possibility that these
structures are an artifact of methanol ¢xation (Fig. 2E). Our
results suggest that XIAP-immunoreactive ring-like structures
are present in HeLa cells throughout the cell cycle, become
undetectable during S phase, and re-form after cytokinesis.
The signi¢cance of these XIAP-immunoreactive structures re-
mains to be determined.
3.4. Chk1 binds the BIR3 domain of XIAP in vitro
Chk1 shares an N-terminal motif with XIAP-binding pro-
teins that targets these proteins to the XIAP BIR3 domain
(Fig. 1). To determine whether Chk1 may interact with the
BIR3 domain of XIAP as well, we performed in vitro binding
experiments using lysates of HEK293 cells transiently trans-
fected with hChk1 or with enhanced green £uorescent protein.
These lysates were incubated with a GST fusion of the XIAP
BIR3 domain (GST-XIAP(BIR3)) or with GST alone as a
control. Chk1-immunoreactive material was detected in com-
plexes pulled down from lysates of HEK293 cells when GST-
XIAP(BIR3), but not when GST alone, was included in the
reaction (Fig. 3A). An additional band of slightly slower ap-
parent mobility was present in complexes pulled down by
GST-XIAP(BIR3); this may correspond to endogenous
Chk1. Thus hChk1, and possibly endogenous Chk1, bound
the BIR3 domain of XIAP in vitro.
3.5. Chk1 binds the BIR3 domain of cIAP1 in vitro
BIR3 domains found in IAP family members share a sig-
ni¢cant degree of homology and are thought to display gen-
erally similar binding preferences. To determine whether
hChk1 may interact with other BIR3 domains in the IAP
family, we performed GST pulldown experiments using a
GST fusion of the BIR3 domain of cIAP1 (GST-cIAP(BIR3))
as a bait. We found that GST-cIAP(BIR3) pulled down Chk1-
immunoreactive material both from untreated HEK293 cells
and from cells expressing hChk1 (Fig. 3B, lanes 3 and 6).
These results indicate that GST-cIAP1(BIR3) can bind both
endogenous and transiently expressed Chk1 in vitro. Even
though we observed higher amounts of Chk1-immunoreactive
material pulled down with GST-cIAP(BIR3) than with GST-
XIAP(BIR3) (Fig. 3B, compare lanes 2 and 5 to lanes 3 and
6), no conclusion about the relative a⁄nities of binding of
GST-XIAP(BIR3) and GST-cIAP(BIR3) to Chk1 can be
made given the non-quantitative nature of the GST pulldown
assays performed. The di¡erence in mobility observed for
Chk1-immunoreactive bands present in lysates from untreated
cells in panels A and B may be due to di¡erences in the
resolving ranges of the polyacrylamide gels used in these ex-
periments (7% Tris-acetate as compared to 10% Bis-Tris poly-
acrylamide gels).
3.6. The interaction of Chk1 with the BIR3 domain of XIAP,
but not cIAP1, depends on an N-terminal AVP motif in
Chk1
To determine whether the N-terminal four residues homol-
ogous to a BIR3 domain-targeting motif in hChk1 may func-
tion as a BIR3-targeting sequence, we generated full-length
hChk1 mutants in which the motif AVPF was mutated to
GVPF (hChk1-GV) or GGPF (hChk1-GG). Lysates from
HEK293 cells expressing wild-type hChk1, hChk1-GV and
hChk1-GG were tested in GST pulldown experiments using
Fig. 3. A: Lysates of HEK293 cells treated as indicated were used in GST pulldown assays as described in Section 2. Pulled-down complexes
were washed, resolved in gels and probed with monoclonal anti-Chk1(G4) antibody (Santa Cruz Biotechnology). B: HEK293 cells were left un-
treated or transfected with the indicated expression vectors, lysed and precleared and then incubated with the indicated GST fusion proteins.
Lysates and pulled-down complexes were resolved in gels and probed with anti-Chk1(G4) antibody.
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GST-XIAP(BIR3) or GST-SAP97 as a control. No Chk1 im-
munoreactivity was detected in complexes pulled down by
GST-XIAP(BIR3) from cells transiently expressing the N-ter-
minal mutants hChk1-GV or hChk1-GG (Fig. 3B, lanes 8 and
11), even when the immunoblots were exposed to ¢lm for
extended periods of time (up to 30 min; not shown). These
results indicate that mutation of the N-terminal motif AVPF
to GVPF or GGPF in hChk1 is su⁄cient to abolish its inter-
action with the BIR3 domain of XIAP in vitro. A more rap-
idly migrating Chk1-immunoreactive band was found in ly-
sates of cells expressing hChk1 N-terminal mutants but not in
cells expressing wild-type hChk1 (Fig. 3B, compare input
lanes hChk1-GV, hChk1-GG and hChk1), which suggests
that endogenous and/or transiently expressed Chk1 is proteo-
lytically cleaved or degraded in the presence of hChk1 N-ter-
minal mutants. However, in a manner similar to what has
been described for kinase-dead and also for Chk1 phosphor-
ylation mutants [19], we did not observe any dominant-neg-
ative e¡ect of N-terminal mutants with respect to endogenous
wild-type Chk1 in DNA damage-induced cell cycle arrest or in
the control of apoptosis in transient transfection experiments.
It was also conceivable that wild-type Chk1 might have a
‘dominant-negative’, pro-apoptotic e¡ect through the dis-
placement of processed caspase-9 and Smac/DIABLO from
binding to the BIR3 domain of XIAP. However, in a manner
similar to what we observed for the N-terminal Chk1 mutants,
wild-type Chk1 did not have an e¡ect on cell death in tran-
sient transfection assays (data not shown).
We conclude that the association between Chk1 and the
BIR3 domain of XIAP in vitro requires the presence of an
intact N-terminal AVP motif in hChk1.
In contrast to what we observed for GST-XIAP(BIR3),
there was no di¡erence in the ability of GST-cIAP(BIR3) to
bind hChk1-GV and hChk1-GG mutants vs. wild-type hChk1
(Fig. 3B, lanes 6, 9 and 12). The relatively higher amounts of
wild-type hChk1 found in complexes pulled down with GST-
cIAP1(BIR3) with respect to hChk1-GV and hChk1-GG may
be due to di¡erences in the levels of expression of wild-type
hChk1 and hChk1-GV and -GG mutants. These results sug-
gest that the interaction between hChk1 and the BIR3 domain
of cIAP1 does not depend on the hChk1 N-terminal AVP
motif. More rapidly migrating Chk1-immunoreactive bands
were also present in the complexes pulled down by GST-
cIAP1(BIR3), supporting the notion that they represent cleav-
age products of hChk1 N-terminal mutants, or of endogenous
Chk1. The use of untagged hChk1 constructs in the present
studies precluded the distinction between these two possibil-
ities.
3.7. Chk1 and XIAP interact in lysates from synchronized
HeLa cells
To determine whether Chk1 and XIAP may interact in cell
lysates, we performed immunoprecipitation experiments using
lysates of synchronized HeLa cells progressing through G2
and undergoing mitosis (6.5 h and 8.5 h after release, respec-
tively) (Figs. 4 and 2B,C). Detection of XIAP and Chk1 in
immunoprecipitated complexes was complicated by the fact
that both proteins and the immunoglobulin G heavy chain
(IgGHC) are of similar size and migrate in denaturing gels
at almost identical apparent relative molecular masses. To
reduce IgGHC cross-reactivity on the membranes, we used
an agarose conjugate of the rabbit polyclonal anti-Chk1(FL-
476) antibody that was extensively washed to reduce the
amount of unbound IgGs present. Also, we used pre-adsorbed
secondary antibodies at high dilutions (to minimize cross-spe-
cies reactivity of the IgGHCs) and resolved the immunopre-
cipitated complexes in 6% Tris-acetate gels. A prominent
XIAP-immunoreactive band was found in complexes immu-
noprecipitated with agarose-conjugated anti-Chk1 antibody
from lysates of synchronized HeLa cells traversing G2 (6.5
h, Fig. 4). Unexpectedly, the amount of XIAP coimmunopre-
cipitated with anti-Chk1 antibody from HeLa cells in mitosis
(8.5 h) was lower than that present in lysates from cells in G2
(6.5 h). As compartmentalization is not preserved when cells
are lysed, it is possible that the total amount of Chk1 protein
in cells traversing G2 is higher than in those undergoing mi-
tosis. Indeed, we observed slightly lower amounts of total
Chk1 protein (but not of XIAP) in lysates from HeLa cells
8.5 h after release from a double-thymidine block (Fig. 2D).
Low levels of immunoreactivity were also observed in com-
plexes immunoprecipitated from HeLa lysates with an agarose
conjugate of rabbit IgG, which may correspond to small
amounts of IgGHC released from the agarose beads at the
time of heating of the samples in preparation for the electro-
phoretic run. These results indicate that XIAP is present in a
complex with Chk1 in lysates of synchronized HeLa cells.
4. Discussion
The results presented here suggest that a four-residue N-ter-
minal motif homologous to a BIR3-targeting sequence may be
present in Chk1. This motif was required for the interaction of
hChk1 with the BIR3 domain of XIAP in vitro. It is possible
that the N-terminus of Chk1 interacts with the same binding
groove on the BIR3 domain of XIAP that mediates the inter-
action of XIAP with processed caspase-9 and Smac/DIABLO.
Even though it is conceivable that Chk1 binding to XIAP
might displace activated caspase-9 and thus be pro-apoptotic,
we did not ¢nd any e¡ect of the expression of wild-type Chk1
on cell death in transient transfection assays (data not shown).
Furthermore, the activation of apoptosis in blastocysts in the
absence of Chk1 [5] suggests that Chk1 might in fact have a
Fig. 4. Synchronized HeLa cells were lysed at the indicated times
after release and subjected to immunoprecipitation with an agarose-
conjugated anti-Chk1(FL-476) polyclonal antibody or with an aga-
rose conjugate of non-speci¢c rabbit IgG. Immunoprecipitated com-
plexes were resolved in Tris-acetate gels and incubated with anti-
XIAP monoclonal antibodies.
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function in the suppression, not in the activation, of apoptosis
during cell division. To test this hypothesis, we transiently
expressed kinase-active Chk1 mutants in which the N-terminal
BIR3 binding motif was obliterated by point mutations
(hChk1-GV and hChk1-GG) in HEK293 cells, but did not
detect an e¡ect on cell survival or on cell cycle progression
in the presence or absence of DNA damage, possibly owing to
the presence of endogenous Chk1 in HEK293 cells (data not
shown). That the overexpression of Chk1 mutants, including
those that abolish its kinase function, does not interfere with
the function of endogenous Chk1 has been documented by
others [19]. Thus, further studies will be required to assess
the potential contribution of the N-terminal sequences of
Chk1 to the modulation of apoptosis through the interaction
with XIAP, or to its function at the G2/M checkpoint. Elu-
cidation of the signi¢cance of the interaction between Chk1
and XIAP may require the construction of N-terminal mutant
hChk1 knock-in embryonic stem cell lines, an experiment that
we have attempted so far without success.
Our results suggest that interaction of Chk1 and XIAP is
transient and restricted to metaphase, probably immediately
after nuclear envelope breakdown. In cells undergoing mito-
sis, Chk1 and XIAP colocalized in juxtaposition with con-
densed chromosomes aligned at the metaphase plate.
The level of ectopic expression of N-terminally mutated
Chk1 cDNA constructs was lower than that of wild-type
Chk1. This observation suggests that the levels of mutant
hChk1 expression in cells might be regulated at the post-tran-
scriptional level. Inhibition of proteasome activity, however,
did not have any e¡ect on the levels of either endogenous or
transiently expressed mutant or wild-type hChk1 in 293 cells.
Chk1 may be the only IAP-interacting protein described to
date that has not been directly implicated in the control of
apoptosis. However, indirect evidence has been presented:
removal of Chk1 function results in embryonic lethality asso-
ciated with massive, p53-independent apoptosis in blastocysts,
suggesting that Chk1 is essential for the survival of mamma-
lian cells even in the absence of DNA damage. A role for
Chk1 in the control of unperturbed cell cycle progression
was recently con¢rmed by experiments using Chk1 siRNA
[4]. The study of the interaction between Chk1 and XIAP
may help to shed light on mechanisms that modulate apopto-
sis during the DNA damage-activated G2/M checkpoint, and
possibly at the time of entry into mitosis during normal cell
cycle progression, as well.
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